Light Mode
$0.2830 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2830, and at the day’s high of $0.2847
-3.38 (-92.27%) / 6M
Momentum, market sentiment, and recent alerts
LABT reads poor: the 12-month move is -96.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.